|
|
|
41
|
23716
|
XYLOMETAZOLINE 0.1% NASAL DR (KWA)
|
XYLOMETAZOLINE
|
XYLOMETAZOLINE
|
15ML
|
A
|
3.56
|
3.561
|
BOTT
|
1
|
BOX
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
5232
|
EENT VASOCONSTRICTORS
|
2024-04-01
|
2026-03-31
|
|
NASAL
|
0
|
EENT VASOCONSTRICTORS
|
|
|
|
|
40
|
23717
|
XYLOMETAZOLINE 0.1% NASAL DR (CIR/AHI)
|
XYLOMETAZOLINE
|
XYLOMETAZOLINE
|
10ML
|
A
|
2.66
|
2.66
|
NASAL DROP
|
1
|
BOTT
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
5232
|
EENT VASOCONSTRICTORS
|
2022-04-01
|
2022-09-30
|
|
NASAL
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
2022-03-29
|
|
|
|
40
|
2371E
|
OTRIVINE 0.1% NASAL DR (GSK/COL) XYLOMETAZOLI
|
XYLOMETAZOLINE
|
OTRIVINE
|
10ML
|
A
|
5.79
|
5.79
|
NASAL DROP
|
1
|
BOTT
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
5232
|
EENT VASOCONSTRICTORS
|
2022-04-01
|
2024-03-31
|
|
NASAL
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
2371E
|
OTRIVINE 0.1% NASAL DR (GSK) XYLOMETAZOL (C)
|
XYLOMETAZOLINE
|
OTRIVINE
|
10ML
|
C
|
6.09
|
6.089
|
BOTT
|
1
|
BOTT
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
5232
|
EENT VASOCONSTRICTORS
|
2024-04-01
|
2026-03-31
|
|
NASAL
|
0
|
EENT VASOCONSTRICTORS
|
|
|
|
|
42
|
2371E
|
OTRIVINE 0.1% NASAL DR (GSK) XYLOMETAZOL
|
XYLOMETAZOLINE
|
OTRIVINE
|
10ML
|
C
|
6.39
|
6.39
|
BOTT
|
1
|
BOTT
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
AVENTA BARBADOS
|
|
5232
|
EENT VASOCONSTRICTORS
|
2026-04-01
|
|
|
NASAL
|
0
|
EENT VASOCONSTRICTORS
|
|
|
|
|
42
|
2371P
|
XYLOMETAZOLINE 0.1% NASAL DR (FSB)
|
XYLOMETAZOLINE
|
XYLOMETAZOLINE
|
15ML
|
A
|
1.50
|
1.50
|
BOTT
|
1
|
|
FSB
|
FLAGSHIP BIOTECH
|
STO
|
BRYDEN STOKES LTD
|
|
5232
|
EENT VASOCONSTRICTORS
|
2026-04-01
|
|
Add to Contract as Cat A
|
NASAL
|
0
|
EENT VASOCONSTRICTORS
|
2026-03-05
|
|
|
|
40
|
23728
|
OTRIVINE MDI 0.1% NASAL SP (GSK/COL) XYLOMETA
|
XYLOMETAZOLINE
|
OTRIVINE MDI
|
10ML
|
C
|
4.38
|
4.38
|
NASAL SPRAY
|
0
|
BOTT
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
5232
|
EENT VASOCONSTRICTORS
|
2022-04-01
|
2024-03-31
|
|
NASAL
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
23728
|
OTRIVINE MDI 0.1% NASAL SP (GSK) XYLOMET (C)
|
XYLOMETAZOLINE
|
OTRIVINE MDI
|
10ML
|
C
|
4.59
|
4.594
|
BOTT
|
1
|
BOTT
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
5232
|
EENT VASOCONSTRICTORS
|
2024-04-01
|
2026-03-31
|
|
NASAL
|
0
|
EENT VASOCONSTRICTORS
|
|
|
|
|
42
|
23728
|
OTRIVINE MDI 0.1% NASAL SP (GSK) XYLOMET
|
XYLOMETAZOLINE
|
OTRIVINE MDI
|
10ML
|
C
|
4.59
|
4.59
|
BOTT
|
1
|
BOTT
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
AVENTA BARBADOS
|
|
5232
|
EENT VASOCONSTRICTORS
|
2026-04-01
|
|
|
NASAL
|
0
|
EENT VASOCONSTRICTORS
|
|
|
|
|
40
|
2372K
|
OTRIVINE 0.1% NASAL SP (GSK/COL) XYLOMETAZOLI
|
XYLOMETAZOLINE
|
OTRIVINE
|
10ML
|
C
|
4.78
|
4.78
|
NASAL SPRAY
|
0
|
BOTT
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
5232
|
EENT VASOCONSTRICTORS
|
2022-04-01
|
2024-03-31
|
|
NASAL
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
2372K
|
OTRIVINE 0.1% NASAL SP (GSK) XYLOMETAZOL (C)
|
XYLOMETAZOLINE
|
OTRIVINE
|
10ML
|
C
|
5.03
|
5.0289
|
BOTT
|
1
|
BOTT
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
5232
|
EENT VASOCONSTRICTORS
|
2024-04-01
|
2026-03-31
|
|
NASAL
|
0
|
EENT VASOCONSTRICTORS
|
|
|
|
|
42
|
2372K
|
OTRIVINE 0.1% NASAL SP (GSK) XYLOMETAZOL
|
XYLOMETAZOLINE
|
OTRIVINE
|
10ML
|
C
|
5.27
|
5.27
|
BOTT
|
1
|
BOTT
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
AVENTA BARBADOS
|
|
5232
|
EENT VASOCONSTRICTORS
|
2026-04-01
|
|
|
NASAL
|
0
|
EENT VASOCONSTRICTORS
|
|
|
|
|
41
|
2372T
|
XYLOMETAZOLINE 0.1% NASAL SP (KWA)
|
XYLOMETAZOLINE
|
XYLOMETAZOLINE
|
10ML
|
A
|
2.96
|
2.963
|
BOTT
|
1
|
BOTT
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
5232
|
EENT VASOCONSTRICTORS
|
2024-04-01
|
2026-03-31
|
|
NASAL
|
0
|
EENT VASOCONSTRICTORS
|
|
|
|
|
40
|
2372U
|
XYLOMETAZOLINE 0.1% NASAL SP (FSB/ATB)
|
XYLOMETAZOLINE
|
XYLOMETAZOLINE
|
10ML
|
A
|
3.53
|
3.53
|
NASAL SPRAY
|
1
|
BOTT
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
5232
|
EENT VASOCONSTRICTORS
|
2022-04-01
|
2024-03-31
|
|
NASAL
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
42
|
2372X
|
XYLOMETAZOLINE 0.1% NASAL SP (FSB)
|
XYLOMETAZOLINE
|
XYLOMETAZOLINE
|
10ML
|
A
|
2.42
|
2.42
|
BOTT
|
1
|
BOTT
|
FSB
|
FLAGSHIP BIOTECH
|
STO
|
BRYDEN STOKES LTD
|
|
5232
|
EENT VASOCONSTRICTORS
|
2026-04-01
|
|
Add to Contract as Cat A
|
NASAL
|
0
|
EENT VASOCONSTRICTORS
|
2026-03-05
|
|
|
|
40
|
23739
|
OTRIVINE 0.05% NASAL DR (GSK/COL) XYLOMETAZOL
|
XYLOMETAZOLINE
|
OTRIVINE
|
10ML
|
A
|
4.70
|
4.70
|
NASAL DROP
|
1
|
BOTT
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
5232
|
EENT VASOCONSTRICTORS
|
2022-04-01
|
2024-03-31
|
|
NASAL
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
23739
|
OTRIVINE 0.05% NASAL DR (GSK) XYLOMETAZO (C)
|
XYLOMETAZOLINE
|
OTRIVINE
|
10ML
|
C
|
4.95
|
4.9473
|
BOTT
|
1
|
BOTT
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
5232
|
EENT VASOCONSTRICTORS
|
2024-04-01
|
2026-03-31
|
|
NASAL
|
0
|
EENT VASOCONSTRICTORS
|
|
|
|
|
42
|
23739
|
OTRIVINE 0.05% NASAL DR (GSK) XYLOMETAZO
|
XYLOMETAZOLINE
|
OTRIVINE
|
10ML
|
A
|
5.19
|
5.19
|
BOTT
|
1
|
BOTT
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
AVENTA BARBADOS
|
|
5232
|
EENT VASOCONSTRICTORS
|
2026-04-01
|
|
|
NASAL
|
0
|
EENT VASOCONSTRICTORS
|
|
|
|
|
41
|
2373E
|
XYLOMETAZOLINE 0.05% NASAL DR (KWA)
|
XYLOMETAZOLINE
|
XYLOMETAZOLINE
|
15ML
|
A
|
2.61
|
2.6096
|
BOTT
|
1
|
BOX
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
5232
|
EENT VASOCONSTRICTORS
|
2024-04-01
|
2026-03-31
|
|
NASAL
|
0
|
EENT VASOCONSTRICTORS
|
|
|
|
|
40
|
2373S
|
XYLOMETAZOLINE 0.05% NASAL DR (CIR/AHI)
|
XYLOMETAZOLINE
|
XYLOMETAZOLINE
|
10ML
|
A
|
2.31
|
2.31
|
NASAL DROP
|
1
|
BOTT
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
5232
|
EENT VASOCONSTRICTORS
|
2022-04-01
|
2022-09-30
|
|
NASAL
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
2022-03-29
|